Adjuvant icotinib for resected EGFR-mutated stage II-IIIA non-small-cell lung cancer (ICTAN, GASTO1002): a randomized comparison study.
Li N, Ou W, Cheng C, You J, Yang L, Chen FX, Liang Y, Yang Z, Wang BX, Chang ZH, Lin YB, Yang W, Xu F, Ding G, Chen XS, Hu R, Li S, Jiang H, Hu XX, Long H, Wang SY.
Li N, et al. Among authors: lin yb.
Signal Transduct Target Ther. 2025 Aug 28;10(1):273. doi: 10.1038/s41392-025-02358-w.
Signal Transduct Target Ther. 2025.
PMID: 40866342
Free PMC article.
Clinical Trial.